Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
In Guru Portfolios
Manager | Fund | Portfolio Weight (%) | Change |
|---|---|---|---|
| Kenneth Griffin | CITADEL ADVISORS LLC | 0.0% | -0.00% |
| Steven Cohen | Point72 Asset Management, L.P. | 0.0% | +0.00% |
About
Streamex Corp., previously known as BioSig Technologies, Inc., officially assumed its new name on September 12, 2025, after completing a merger with Streamex Exchange Corporation. The company has since pivoted its core business strategy, moving from healthcare technology to specialize in the tokenization of tangible assets. A primary objective of this shift is to integrate the gold and broader commodities markets into blockchain technology. To facilitate this, Streamex provides robust, institutional-level infrastructure for asset tokenization, which is uniquely underpinned by a treasury denominated in gold.
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks.
Target Price
The average target price of BSGM is 10.0 and suggests 64% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa